Hepatitis C Virus Mediated Inhibition of miR-181c Activates ATM Signaling and Promotes Hepatocyte Growth

被引:21
作者
Patra, Tapas [1 ]
Meyer, Keith [1 ]
Ray, Ratna B. [2 ]
Ray, Ranjit [1 ,3 ]
机构
[1] St Louis Univ, Dept Internal Med, 1100 S Grand Blvd, St Louis, MO 63104 USA
[2] St Louis Univ, Dept Pathol, 1100 South Grand Blvd, St Louis, MO 63104 USA
[3] St Louis Univ, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA
基金
美国国家卫生研究院;
关键词
INDUCED UP-REGULATION; DNA-DAMAGE RESPONSE; CELL-CYCLE; ATAXIA-TELANGIECTASIA; KINASE; INFECTION; MICRORNAS; INVASION; PHOSPHORYLATION; PROLIFERATION;
D O I
10.1002/hep.30893
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims Hepatitis C virus (HCV) infection promotes hepatocyte growth and progress to hepatocellular carcinoma. We previously observed that HCV infection of hepatocytes transcriptionally down-regulates miR-181c expression through CCAAT/enhancer binding protein beta (C/EBP-beta). Here, we examined the role of miR-181c in the regulation of cell cycle progression in relation to HCV infection. In silico analysis suggested that ataxia-telangiectasia mutated (ATM) protein, a protein kinase, is a direct target of miR-181c. ATM is a central mediator of response for cellular DNA double-strand break. Approach and Results Our results demonstrated that ATM expression is higher in HCV-infected hepatocytes and chronic HCV-infected liver biopsy specimens. We have shown a direct interaction of miR-181c with the 3 ' untranslated region of ATM, and the presence of ATM in miR-181c-associated RNA-induced silencing complex. Exogenous expression of miR-181c inhibited ATM expression and activation of its downstream molecules, Chk2 and Akt. On the other hand, introduction of anti-miR-181c restored ATM and phosphorylated Akt. Furthermore, introduction of miR-181c significantly inhibited phospho-cyclin-dependent kinase 2 (CDK2) and cyclin-A expression, arresting cell cycle progression, whereas overexpression of miR-181c promoted apoptosis of HCV-infected hepatocytes and can be inhibited by overexpression of ATM from a clone lacking miR-181c binding sites. In addition, miR-181c significantly regressed tumor growth in the xenograft human hepatocellular carcinoma mouse model. Conclusions Together, our results suggest that HCV infection suppresses miR-181c in hepatocytes, resulting in ATM activation and apoptosis inhibition for promotion of cell cycle progression. The results provide mechanistic insight into understanding the role of miR-181c in HCV-associated hepatocyte growth promotion, and may have the potential for therapeutic intervention.
引用
收藏
页码:780 / 793
页数:14
相关论文
共 50 条
  • [1] The DNA damage sensors ataxia-telangiectasia mutated kinase and checkpoint kinase 2 are required for hepatitis C virus RNA replication
    Ariumi, Yasuo
    Kuroki, Misao
    Dansako, Hiromichi
    Abe, Ken-Ichi
    Ikeda, Masanori
    Wakita, Takaji
    Kato, Nobuyuki
    [J]. JOURNAL OF VIROLOGY, 2008, 82 (19) : 9639 - 9646
  • [2] Novel Therapeutic Approaches for Hepatitis C
    Au, J. S.
    Pockros, P. J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 (01) : 78 - 88
  • [3] Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis
    Bandiera, Simonetta
    Pernot, Sophie
    El Saghire, Hussein
    Durand, Sarah C.
    Thumann, Christine
    Crouchet, Emilie
    Ye, Tao
    Fofana, Isabel
    Oudot, Marine A.
    Barths, Jochen
    Schuster, Catherine
    Pessaux, Patrick
    Heim, Markus H.
    Baumert, Thomas F.
    Zeisel, Mirjam B.
    [J]. JOURNAL OF VIROLOGY, 2016, 90 (14) : 6387 - 6400
  • [4] Hepatitis C Virus Infection and Hepatic Stellate Cell Activation Downregulate miR-29: miR-29 Overexpression Reduces Hepatitis C Viral Abundance in Culture
    Bandyopadhyay, Sarmistha
    Friedman, Robin C.
    Marquez, Rebecca T.
    Keck, Kathy
    Kong, Benjamin
    Icardi, Michael S.
    Brown, Kyle E.
    Burge, Christopher B.
    Schmidt, Warren N.
    Wang, Yulei
    McCaffrey, Anton P.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2011, 203 (12) : 1753 - 1762
  • [5] DNA damage signalling guards against activated oncogenes and tumour progression
    Bartek, J.
    Bartkova, J.
    Lukas, J.
    [J]. ONCOGENE, 2007, 26 (56) : 7773 - 7779
  • [6] MicroRNAs: Target Recognition and Regulatory Functions
    Bartel, David P.
    [J]. CELL, 2009, 136 (02) : 215 - 233
  • [7] MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004)
    Bartel, David P.
    [J]. CELL, 2007, 131 (04) : 11 - 29
  • [8] Hepatitis C Virus Activates the mTOR/S6K1 Signaling Pathway in Inhibiting IRS-1 Function for Insulin Resistance
    Bose, Sandip K.
    Shrivastava, Shubham
    Meyer, Keith
    Ray, Ratna B.
    Ray, Ranjit
    [J]. JOURNAL OF VIROLOGY, 2012, 86 (11) : 6315 - 6322
  • [9] Small molecules with big roles in microRNA chemical biology and microRNA-targeted therapeutics
    Fan, Rengen
    Xiao, Chaocheng
    Wan, Xinqiang
    Cha, Wenzhang
    Miao, Yufeng
    Zhou, Yong
    Qin, Chenglin
    Cui, Ting
    Su, Fenglian
    Shan, Xiangxiang
    [J]. RNA BIOLOGY, 2019, 16 (06) : 707 - 718
  • [10] DNA Damage Signaling-Induced Cancer Cell Reprogramming as a Driver of Tumor Relapse
    Filipponi, Doria
    Emelyanov, Alexander
    Muller, Julius
    Molina, Clement
    Nichols, Jennifer
    Bulavin, Dmitry V.
    [J]. MOLECULAR CELL, 2019, 74 (04) : 651 - +